
Archan Khandekar
@khandekararchan
Urologic Oncology @dsui_miami_uro
All things #AI, One algorithm at a time.
ID: 26678945
26-03-2009 03:29:09
5,5K Tweet
1,1K Followers
1,1K Following




Representing Desai Sethi Urology Institute at the Miami Half Marathon! Thank you Archan Khandekar for the partnership and support in and outside the hospital! #MiamiHalfMarathon


Relive the 3rd annual #DSUIOnTheBeach meeting through our recap video! This innovative meeting showcases groundbreaking advancements & research in the field of #urology! Join us next year, January 16-18, 2026. Dipen J Parekh, M.D. Raveen Syan, MD, FPMRS Bruno Nahar youtube.com/watch?v=3EBTrb…

Had a great time representing Desai Sethi Urology Institute at the Dolphins Cancer Challenge cycling event with an amazing team! Sylvester Comprehensive Cancer Center sanoj punnen Chad Ritch


No one becomes a clinician to do paperwork, but it's becoming a bigger and bigger administrative burden, taking time and attention away from actually treating and supporting patients. That’s why we’re introducing Microsoft Dragon Copilot, the industry’s first AI assistant for

Today at #AUA25, Archan Khandekar took the stage to showcase his work on how AI is transforming operative reporting. By objectively evaluating surgical documentation , an AI surgical scribe is where the future lies. Miller Medicine


#AUA2025 Excited to have presented on genomic data gathered for 10yrs. in the Miami Active Surveillance Trial (MAST) ran by sanoj punnen at Desai Sethi Urology Institute. ⚠️ GG1 cancer foci are independent - genomic scores do not predict higher-grade disease elsewhere in the prostate!


At #AUA25, sanoj punnen discussed how #PSMA tracers enhance #prostatecancer staging. PSMA expression increases 100–1000x in prostate cancer, allowing detection at low levels; higher PSMA scores correlate with higher tumor stage and grade. Miller Medicine


HOT OFF THE PRESS New JAMA Surgery original article from our team Surgical Performance Metrics for 1-Year Patient-Reported Outcomes After Radical Prostatectomy. Using performance metrics (technical skills and surgical gestures) collected from videos, we are able to anticipant


Shared three posters at the #aua2025 this year. Early steps in our homegrown AI efforts at Desai Sethi Urology Institute. Built by our team, with real clinical problems in mind. More to come. #codetoclinic



We’re proud to share that the University of Miami Board of Trustees has unanimously endorsed Dr. Dipen J. Parekh (Dipen J Parekh, M.D.) as the next Chief Executive Officer of UHealth and Executive Vice President for Health Affairs at the University of Miami (University of Miami). UHealth and



Our article in this edition of Journal of Urology Dipen J Parekh, M.D. Mark L. Gonzalgo, MD, PhD, MBA Desai Sethi Urology Institute Journal of Urology

We are thrilled to announce that Jessica Delgado, MD will be keeping her talent with us Desai Sethi Urology Institute . Huge congrats to Dr Delgado and all the Society of Urologic Oncology match applicants!


Honored to receive the 2025 Faculty Teacher of the Year Award from the Desai Sethi Urology Institute residents. Teaching—and learning from—our residents and fellows is truly the best part of my job. Wishing all the best to the incredible Class of 2025! 👏🎓


Join us in celebrating Mark L. Gonzalgo, M.D., Ph.D., M.D., Ph.D., M.B.A., as he steps into his new role as Chair of the Department of Urology Desai Sethi Urology Institute and Miller Medicine! 🩺 A nationally recognized leader in urologic care, research, and education, Dr. Gonzalgo will oversee and lead


⚠️ Check out our latest paper on genomics in the Miami Active Surveillance Trial (MAST): 🔹️ Genomic scores were similar between GG1 cores with vs. without GG2+ cancer elsewhere in the prostate. 🔹️PCa is multifocal and each focus is genomically independent. sanoj punnen